Amy L. Holstege

Endocrinology
255 Hospital Drive
Glen Burnie, MD 21061

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors.

SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors.

Journal: The Annals of pharmacotherapy
Published: November 27, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026